+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Interventional Oncology Market By Product, By Cancer Type, and By Procedure: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018-2025

  • ID: 5143946
  • Report
  • September 2019
  • Region: Global
  • 150 pages
  • Zion Market Research

Enquire about COVID-19 updates for this product.

Enquire Now
The report analyzes and forecasts the interventional oncology market on a global and regional level. The study offers past data from 2017 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The assessment of interventional oncology market dynamics gives a brief thought about the drivers and restraints of the interventional oncology market along with their impact on the demand over the years to come. Additionally, the report also includes the study of opportunities available in the interventional oncology market on a global level.

The report gives a transparent view of the interventional oncology market. We have included a detailed competitive scenario and portfolio of the leading vendors operating in the interventional oncology market. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces Model for the interventional oncology market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The interventional oncology market is fragmented on the basis of product, cancer type, procedure, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players involved in the interventional oncology market are Boston Scientific, Terumo Corporation, Medtronic, BTG, Ethicon, AngioDynamics, Merit Medical Systems, Sirtex Medical, Eckert & Ziegler, BEBIG, Siemens Healthineers, Varian Medical Systems, and HealthTronics.

This report segments the global interventional oncology market into:

Global Interventional Oncology Market: Product Analysis
  • Embolization Devices
  • Radioembolic Agents
  • Non-Radioactive Agents
  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Others
  • Support Devices
  • Guidewires
  • Microcatheter
Global Interventional Oncology Market: Cancer Type Analysis
  • Kidney Cancer
  • Lung Cancer
  • Breast Cancer
  • Liver Cancer
  • Bone Metastasis Cancer
  • Others
Global Interventional Oncology Market: Procedure Analysis
  • Thermal Tumor Ablation
  • Non-Thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization
  • Transcatheter Arterial Radioembolization
  • Transcatheter Arterial Embolization
Global Interventional Oncology Market: Regional Analysis
  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Interventional Oncology Market, 2017-2025 (USD Million)
    • 2.2. Interventional Oncology Market: Snapshot
  • Chapter 3. Interventional Oncology Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Rapid Growth in the Geriatric Population
      • 3.2.2. Technological advancements
      • 3.2.3. Increasing government initiatives for cancer treatment
      • 3.2.4. Increasing awareness in developing nations
      • 3.2.5. Advanced research and development
      • 3.2.6. Increase in cancer patients due to changing lifestyle
      • 3.2.7. Growing elderly population
    • 3.3. Market restraints
      • 3.3.1. The high cost of treatment
      • 3.3.2. Lack of awareness in underdeveloped countries
      • 3.3.3. Lack of proper reimbursement policies
    • 3.4. Opportunities
      • 3.4.1. Evolving market
      • 3.4.2. Advanced technology
      • 3.4.3. Untapped Emerging Market
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product
      • 3.6.2. Market attractiveness analysis, by cancer type
      • 3.6.3. Market attractiveness analysis, by procedure
      • 3.6.4. Market attractiveness analysis, by region
  • Chapter 4. Interventional Oncology Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Interventional oncology market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Interventional Oncology Market - Product Analysis
    • 5.1. Interventional oncology market: Product overview
      • 5.1.1. Interventional oncology Market Revenue, by product, 2018 and 2025
    • 5.2. Embolization Devices
      • 5.2.1. Interventional oncology market for embolization devices, 2017-2025 (USD Million)
    • 5.3. Ablation Devices
      • 5.3.1. Interventional oncology market for ablation devices, 2017-2025 (USD Million)
    • 5.4. Support Devices
      • 5.4.1. Interventional oncology market for support devices, 2017-2025 (USD Million)
  • Chapter 6. Interventional Oncology Market - Cancer Type Analysis
    • 6.1. Interventional oncology market: Cancer type overview
      • 6.1.1. Interventional oncology Market Revenue, by cancer type, 2018 and 2025
    • 6.2. Kidney
      • 6.2.1. Interventional oncology market for kidney cancer, 2017-2025 (USD Million)
    • 6.3. Lung
      • 6.3.1. Interventional oncology market for lung cancer, 2017-2025 (USD Million)
    • 6.4. Breast
      • 6.4.1. Interventional oncology market for breast cancer, 2017-2025 (USD Million)
    • 6.5. Liver
      • 6.5.1. Interventional oncology market for liver cancer, 2017-2025 (USD Million)
    • 6.6. Bone Metastasis
      • 6.6.1. Interventional oncology market for bone metastasis cancer, 2017-2025 (USD Million)
    • 6.7. Others
      • 6.7.1. Interventional oncology market for others, 2017-2025 (USD Million)
  • Chapter 7. Interventional Oncology Market - Procedure Analysis
    • 7.1. Interventional oncology market: procedure overview
      • 7.1.1. Interventional oncology market revenue, by procedure, 2018 and 2025
      • 7.1.2. Thermal Ablation
        • 7.1.2.1. Interventional oncology market for thermal ablation, 2017-2025 (USD Million)
      • 7.1.3. Non-Thermal Ablation
        • 7.1.3.1. Interventional oncology market for non-thermal ablation, 2017-2025 (USD Million)
      • 7.1.4. Transcatheter Arterial Chemoembolization
        • 7.1.4.1. Interventional oncology market for transcatheter arterial chemoembolization, 2017-2025 (USD Million)
      • 7.1.5. Transcatheter Arterial Radioembolization
        • 7.1.5.1. Interventional oncology market for transcatheter arterial radioembolization, 2017-2025 (USD Million)
      • 7.1.6. Transcatheter Arterial Embolization
        • 7.1.6.1. Interventional oncology market for transcatheter arterial embolization, 2017-2025 (USD Million)
  • Chapter 8. Interventional Oncology Market - Regional Analysis
    • 8.1. Global interventional oncology market: Regional overview
      • 8.1.1. Interventional oncology market revenue, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.2.2. North America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.2.3. North America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. interventional oncology market, by product, 2017-2025 (USD Million)
        • 8.2.4.2. The U.S. interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.2.4.3. The U.S. interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada interventional oncology market, by product, 2017-2025 (USD Million)
        • 8.2.5.2. Canada interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.2.5.3. Canada interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.3.2. Europe interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.3.3. Europe interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.3.4. UK
        • 8.3.4.1. UK interventional oncology market, by product, 2017-2025 (USD Million)
        • 8.3.4.2. UK interventional oncology market, by cancer type, 2017-2025 (USD Million)
        • 8.3.4.3. UK interventional oncology market, by procedure, 2017-2025 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.3.5.2. Germany interventional oncology market, by cancer type, 2017-2025 (USD Million)
        • 8.3.5.3. Germany interventional oncology market, by procedure, 2017-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.3.6.2. France interventional oncology market, by cancer type, 2017-2025 (USD Million)
        • 8.3.6.3. France interventional oncology market, by procedure, 2017-2025 (USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.3.7.2. Rest of Europe interventional oncology market, by cancer type, 2017-2025 (USD Million)
        • 8.3.7.3. Rest of Europe interventional oncology market, by procedure, 2017-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.4.2. Asia Pacific interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.4.3. Asia Pacific interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.4.4.2. China interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.4.4.3. China interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan interventional oncology market revenue, byproduct, 2017-2025 (USD Million)
        • 8.4.5.2. Japan interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.4.5.3. Japan interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.4.6.2. India interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.4.6.3. India interventional oncology market revenue, by procedure type, 2017-2025 (USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.4.7.2. Rest of Asia Pacific interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.4.7.3. Rest of Asia Pacific interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.5.2. Latin America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.5.3. Latin America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.5.4.2. Brazil interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.5.4.3. Brazil interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America interventional oncology market revenue, by product, 2017-2025 (USD Million)
        • 8.5.5.2. Rest of Latin America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
        • 8.5.5.3. Rest of Latin America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.6.2. The Middle East and Africa interventional oncology market, by cancer type, 2017-2025 (USD Million)
      • 8.6.3. The Middle East and Africa interventional oncology market, by procedure, 2017-2025 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. Boston Scientific
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Terumo Corporation
      • 9.2.1. overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Medtronic
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. BTG
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Ethicon
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. AngioDynamics
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Merit Medical Systems
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Sirtex Medical
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Eckert & Ziegler
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. BEBIG
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments
Note: Product cover images may vary from those shown
Adroll
adroll